aripiprazole has been researched along with exudates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananjit, S; Badiah, Y; Bulgiba, A; Habil, MH; Hairi, NN; Haslina, MY; Hatim, A; Mahmud, B; Ramli, MA; Said, MA; Sapini, Y; Shah, M; Zafidah, W | 1 |
| Fujii, Y; Ishigooka, J; Iwata, N; Iyo, M; Kishimoto, T; Nakamura, J; Nishimura, R; Shimizu, N; Uchimura, N | 1 |
1 trial(s) available for aripiprazole and exudates
| Article | Year |
|---|---|
Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: a multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Asian People; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections; Japan; Kaplan-Meier Estimate; Malaysia; Male; Philippines; Psychiatric Status Rating Scales; Schizophrenia; Taiwan; Treatment Outcome; Weight Gain | 2015 |
1 other study(ies) available for aripiprazole and exudates
| Article | Year |
|---|---|
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Cross-Sectional Studies; Female; Flupenthixol; Humans; Malaysia; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quinolones; Schizophrenia; Trifluoperazine; Waist Circumference; Young Adult | 2013 |